NexMed nexmed.com


Public lists: Pharma Startups (4729)

NexMed is a Healthcare/Pharmaceuticals / Drugs company based in East Windsor, New Jersey. NexMed's investors include Iroquois Capital, Tang Capital Management, Akros Capital, Trust for Professional Managers - Akros Absolute Return Fund, SDS Capital Partners, Scopia Management, MDNH Partners, Loeb Partners, Southpoint Capital Advisors, Clarion Capital Partners, Solomon Strategic, Gemini Investment Strategies, Tail Wind Fund and Lanphier Capital Management.

NexMed is a Healthcare/Pharmaceuticals / Drugs company based in East Windsor, New Jersey. NexMed's investors include Iroquois Capital, Tang Capital Management, Akros Capital, Trust for Professional Managers - Akros Absolute Return Fund, SDS Capital P...Show all

Company (Alive / Active)

Phone: 609-371-8123

Fax:

89 Twin Rivers Drive
East Windsor, 08520
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NexMed $67.4M Jan 19, 2006

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NexMed Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
BayStar CapitalVenture CapitalLarkspur, California, United StatesUnattributed VC - III, Unattributed VC - II, Unattributed VC
Clarion Capital PartnersPrivate EquityNew York, New York, United StatesUnattributed VC - VI, Unattributed VC - IV, Unattributed VC - III, Unattributed VC
Bristol Capital AdvisorsAsset/Investment ManagementLos Angeles, California, United StatesUnattributed VC - IV
Enable Capital ManagementAsset/Investment ManagementSan Francisco, California, United StatesUnattributed VC - IV
Akros CapitalNew York, New York, United StatesUnattributed VC - VI
See all 30 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods and compositions for treating raynaud's disease Jul 29, 2016 Jan 02, 2018 Patent
Methods and compositions for treating raynaud's disease Jan 07, 2015 Dec 13, 2016 Patent
Stabilized composition for treating psoriasis Oct 02, 2009 Dec 29, 2015 Patent
Alprostadil and dyclonine for treatment of premature ejaculation Aug 20, 2014 Jun 30, 2015 Patent
Alprostadil for treatment of premature ejaculation Aug 20, 2014 Jun 23, 2015 Patent
See all 24 patents